Two studies published in Nature Medicine June 11 contribute to a small body of literature suggesting cells edited with CRISPR-Cas9 may cause cancer. Here are five things to know about the studies and ...
A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...
A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving ...
Antibiotic resistance is racing toward a global crisis, with “superbugs” projected to cause over 10 million deaths annually by 2050. Now, scientists at UC San Diego have unveiled a powerful new CRISPR ...
The Case Western Reserve University Science and Human Rights Coalition will host Andrea Waksmunski, a PhD candidate in the Department of Genetics and Genome Sciences, for a talk titled “Ethics of ...
A group of Chinese scientists have become the first to use the game-changing gene-editing technology CRISPR-Cas9 on humans. Nature reported today that a team from Sichuan University inserted ...
Hosted on MSN
CRISPR and deep learning identify hundreds of human proteins that influence Ebola infection
Although outbreaks of Ebola virus are rare, the disease is severe and often fatal, with few treatment options. Rather than targeting the virus itself, one promising therapeutic approach would be to ...
The 2026 Priestley Medalist and Nobel laureate struggled with finding her way through school before achieving the greatest feats in science ...
Boston – The Influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally. In the U.S. alone, it is estimated that, despite seasonally ...
MarketBeat on MSN
CRISPR Therapeutics gains after earnings as pipeline hope grows
CRISPR Therapeutics AG (NASDAQ: CRSP) stock is up more than 12% after the gene editing pioneer reported its Q4 2025 earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results